nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Cystitis haemorrhagic—Doxorubicin—kidney cancer	0.0228	0.0228	CcSEcCtD
Clavulanate—Induration—Paclitaxel—kidney cancer	0.0193	0.0193	CcSEcCtD
Clavulanate—Pseudomembranous colitis—Paclitaxel—kidney cancer	0.0174	0.0174	CcSEcCtD
Clavulanate—Thrombophlebitis—Temsirolimus—kidney cancer	0.0174	0.0174	CcSEcCtD
Clavulanate—Swelling—Temsirolimus—kidney cancer	0.0171	0.0171	CcSEcCtD
Clavulanate—Hypokalaemia—Temsirolimus—kidney cancer	0.0137	0.0137	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Temsirolimus—kidney cancer	0.0115	0.0115	CcSEcCtD
Clavulanate—Hypokalaemia—Everolimus—kidney cancer	0.0102	0.0102	CcSEcCtD
Clavulanate—Haemoglobin—Pazopanib—kidney cancer	0.00985	0.00985	CcSEcCtD
Clavulanate—Erythema multiforme—Temsirolimus—kidney cancer	0.00984	0.00984	CcSEcCtD
Clavulanate—Hypokalaemia—Erlotinib—kidney cancer	0.00983	0.00983	CcSEcCtD
Clavulanate—Haemorrhage—Pazopanib—kidney cancer	0.0098	0.0098	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Erlotinib—kidney cancer	0.00972	0.00972	CcSEcCtD
Clavulanate—Hypokalaemia—Sorafenib—kidney cancer	0.00884	0.00884	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Sorafenib—kidney cancer	0.00875	0.00875	CcSEcCtD
Clavulanate—Hypokalaemia—Sunitinib—kidney cancer	0.00851	0.00851	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Sunitinib—kidney cancer	0.00842	0.00842	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Erlotinib—kidney cancer	0.00825	0.00825	CcSEcCtD
Clavulanate—Leukopenia—Temsirolimus—kidney cancer	0.00811	0.00811	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Dactinomycin—kidney cancer	0.00797	0.00797	CcSEcCtD
Clavulanate—Convulsion—Temsirolimus—kidney cancer	0.00785	0.00785	CcSEcCtD
Clavulanate—Haemoglobin—Vinblastine—kidney cancer	0.00781	0.00781	CcSEcCtD
Clavulanate—Haemoglobin—Everolimus—kidney cancer	0.00778	0.00778	CcSEcCtD
Clavulanate—Haemorrhage—Vinblastine—kidney cancer	0.00777	0.00777	CcSEcCtD
Clavulanate—Hepatitis—Everolimus—kidney cancer	0.00774	0.00774	CcSEcCtD
Clavulanate—Haemorrhage—Everolimus—kidney cancer	0.00774	0.00774	CcSEcCtD
Clavulanate—Leukopenia—Pazopanib—kidney cancer	0.00764	0.00764	CcSEcCtD
Clavulanate—Haemoglobin—Erlotinib—kidney cancer	0.00751	0.00751	CcSEcCtD
Clavulanate—Haemorrhage—Erlotinib—kidney cancer	0.00747	0.00747	CcSEcCtD
Clavulanate—Hepatitis—Erlotinib—kidney cancer	0.00747	0.00747	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Sorafenib—kidney cancer	0.00742	0.00742	CcSEcCtD
Clavulanate—Anaphylactic shock—Temsirolimus—kidney cancer	0.00739	0.00739	CcSEcCtD
Clavulanate—Thrombophlebitis—Paclitaxel—kidney cancer	0.00725	0.00725	CcSEcCtD
Clavulanate—Thrombocytopenia—Temsirolimus—kidney cancer	0.00724	0.00724	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Sunitinib—kidney cancer	0.00714	0.00714	CcSEcCtD
Clavulanate—Swelling—Paclitaxel—kidney cancer	0.00712	0.00712	CcSEcCtD
Clavulanate—Erythema multiforme—Erlotinib—kidney cancer	0.00706	0.00706	CcSEcCtD
Clavulanate—Hypokalaemia—Gemcitabine—kidney cancer	0.00683	0.00683	CcSEcCtD
Clavulanate—Thrombocytopenia—Pazopanib—kidney cancer	0.00682	0.00682	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Dactinomycin—kidney cancer	0.00676	0.00676	CcSEcCtD
Clavulanate—Haemoglobin—Sorafenib—kidney cancer	0.00675	0.00675	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Gemcitabine—kidney cancer	0.00675	0.00675	CcSEcCtD
Clavulanate—Haemorrhage—Sorafenib—kidney cancer	0.00672	0.00672	CcSEcCtD
Clavulanate—Haemoglobin—Sunitinib—kidney cancer	0.0065	0.0065	CcSEcCtD
Clavulanate—Haemorrhage—Sunitinib—kidney cancer	0.00647	0.00647	CcSEcCtD
Clavulanate—Hepatitis—Sunitinib—kidney cancer	0.00647	0.00647	CcSEcCtD
Clavulanate—Erythema multiforme—Sorafenib—kidney cancer	0.00635	0.00635	CcSEcCtD
Clavulanate—Pain—Temsirolimus—kidney cancer	0.00632	0.00632	CcSEcCtD
Clavulanate—Hepatitis—Dactinomycin—kidney cancer	0.00612	0.00612	CcSEcCtD
Clavulanate—Erythema multiforme—Sunitinib—kidney cancer	0.00611	0.00611	CcSEcCtD
Clavulanate—Leukopenia—Vinblastine—kidney cancer	0.00606	0.00606	CcSEcCtD
Clavulanate—Leukopenia—Everolimus—kidney cancer	0.00603	0.00603	CcSEcCtD
Clavulanate—Pain—Pazopanib—kidney cancer	0.00596	0.00596	CcSEcCtD
Clavulanate—Thrombophlebitis—Capecitabine—kidney cancer	0.00595	0.00595	CcSEcCtD
Clavulanate—Convulsion—Vinblastine—kidney cancer	0.00586	0.00586	CcSEcCtD
Clavulanate—Swelling—Capecitabine—kidney cancer	0.00584	0.00584	CcSEcCtD
Clavulanate—Convulsion—Everolimus—kidney cancer	0.00584	0.00584	CcSEcCtD
Clavulanate—Erythema multiforme—Dactinomycin—kidney cancer	0.00579	0.00579	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00573	0.00573	CcSEcCtD
Clavulanate—Hypokalaemia—Paclitaxel—kidney cancer	0.00571	0.00571	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.00565	0.00565	CcSEcCtD
Clavulanate—Hypersensitivity—Temsirolimus—kidney cancer	0.00545	0.00545	CcSEcCtD
Clavulanate—Thrombocytopenia—Vinblastine—kidney cancer	0.00541	0.00541	CcSEcCtD
Clavulanate—Thrombocytopenia—Everolimus—kidney cancer	0.00539	0.00539	CcSEcCtD
Clavulanate—Leukopenia—Sorafenib—kidney cancer	0.00524	0.00524	CcSEcCtD
Clavulanate—Pruritus—Temsirolimus—kidney cancer	0.00523	0.00523	CcSEcCtD
Clavulanate—Haemoglobin—Gemcitabine—kidney cancer	0.00521	0.00521	CcSEcCtD
Clavulanate—Jaundice cholestatic—Doxorubicin—kidney cancer	0.00521	0.00521	CcSEcCtD
Clavulanate—Thrombocytopenia—Erlotinib—kidney cancer	0.0052	0.0052	CcSEcCtD
Clavulanate—Haemorrhage—Gemcitabine—kidney cancer	0.00519	0.00519	CcSEcCtD
Clavulanate—Diarrhoea—Temsirolimus—kidney cancer	0.00506	0.00506	CcSEcCtD
Clavulanate—Leukopenia—Sunitinib—kidney cancer	0.00504	0.00504	CcSEcCtD
Clavulanate—Pruritus—Pazopanib—kidney cancer	0.00493	0.00493	CcSEcCtD
Clavulanate—Erythema multiforme—Gemcitabine—kidney cancer	0.00491	0.00491	CcSEcCtD
Clavulanate—Convulsion—Sunitinib—kidney cancer	0.00488	0.00488	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.0048	0.0048	CcSEcCtD
Clavulanate—Anaphylactic shock—Sorafenib—kidney cancer	0.00477	0.00477	CcSEcCtD
Clavulanate—Leukopenia—Dactinomycin—kidney cancer	0.00477	0.00477	CcSEcCtD
Clavulanate—Diarrhoea—Pazopanib—kidney cancer	0.00477	0.00477	CcSEcCtD
Clavulanate—Pain—Vinblastine—kidney cancer	0.00472	0.00472	CcSEcCtD
Clavulanate—Pain—Everolimus—kidney cancer	0.0047	0.0047	CcSEcCtD
Clavulanate—Vomiting—Temsirolimus—kidney cancer	0.0047	0.0047	CcSEcCtD
Clavulanate—Hypokalaemia—Capecitabine—kidney cancer	0.00469	0.00469	CcSEcCtD
Clavulanate—Thrombocytopenia—Sorafenib—kidney cancer	0.00467	0.00467	CcSEcCtD
Clavulanate—Rash—Temsirolimus—kidney cancer	0.00466	0.00466	CcSEcCtD
Clavulanate—Dermatitis—Temsirolimus—kidney cancer	0.00466	0.00466	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.00464	0.00464	CcSEcCtD
Clavulanate—Pain—Erlotinib—kidney cancer	0.00454	0.00454	CcSEcCtD
Clavulanate—Thrombocytopenia—Sunitinib—kidney cancer	0.0045	0.0045	CcSEcCtD
Clavulanate—Vomiting—Pazopanib—kidney cancer	0.00443	0.00443	CcSEcCtD
Clavulanate—Rash—Pazopanib—kidney cancer	0.00439	0.00439	CcSEcCtD
Clavulanate—Nausea—Temsirolimus—kidney cancer	0.00439	0.00439	CcSEcCtD
Clavulanate—Dermatitis—Pazopanib—kidney cancer	0.00439	0.00439	CcSEcCtD
Clavulanate—Haemoglobin—Paclitaxel—kidney cancer	0.00437	0.00437	CcSEcCtD
Clavulanate—Haemorrhage—Paclitaxel—kidney cancer	0.00434	0.00434	CcSEcCtD
Clavulanate—Leukopenia—Vincristine—kidney cancer	0.00426	0.00426	CcSEcCtD
Clavulanate—Thrombocytopenia—Dactinomycin—kidney cancer	0.00426	0.00426	CcSEcCtD
Clavulanate—Nausea—Pazopanib—kidney cancer	0.00414	0.00414	CcSEcCtD
Clavulanate—Convulsion—Vincristine—kidney cancer	0.00413	0.00413	CcSEcCtD
Clavulanate—Erythema multiforme—Paclitaxel—kidney cancer	0.00411	0.00411	CcSEcCtD
Clavulanate—Pain—Sorafenib—kidney cancer	0.00408	0.00408	CcSEcCtD
Clavulanate—Hypersensitivity—Vinblastine—kidney cancer	0.00407	0.00407	CcSEcCtD
Clavulanate—Hypersensitivity—Everolimus—kidney cancer	0.00405	0.00405	CcSEcCtD
Clavulanate—Leukopenia—Gemcitabine—kidney cancer	0.00404	0.00404	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00394	0.00394	CcSEcCtD
Clavulanate—Pain—Sunitinib—kidney cancer	0.00393	0.00393	CcSEcCtD
Clavulanate—Pruritus—Everolimus—kidney cancer	0.00389	0.00389	CcSEcCtD
Clavulanate—Anaphylactic shock—Vincristine—kidney cancer	0.00389	0.00389	CcSEcCtD
Clavulanate—Thrombophlebitis—Doxorubicin—kidney cancer	0.00384	0.00384	CcSEcCtD
Clavulanate—Thrombocytopenia—Vincristine—kidney cancer	0.0038	0.0038	CcSEcCtD
Clavulanate—Urticaria—Sorafenib—kidney cancer	0.00379	0.00379	CcSEcCtD
Clavulanate—Diarrhoea—Vinblastine—kidney cancer	0.00378	0.00378	CcSEcCtD
Clavulanate—Diarrhoea—Everolimus—kidney cancer	0.00376	0.00376	CcSEcCtD
Clavulanate—Pruritus—Erlotinib—kidney cancer	0.00375	0.00375	CcSEcCtD
Clavulanate—Pain—Dactinomycin—kidney cancer	0.00372	0.00372	CcSEcCtD
Clavulanate—Anaphylactic shock—Gemcitabine—kidney cancer	0.00369	0.00369	CcSEcCtD
Clavulanate—Diarrhoea—Erlotinib—kidney cancer	0.00363	0.00363	CcSEcCtD
Clavulanate—Thrombocytopenia—Gemcitabine—kidney cancer	0.00361	0.00361	CcSEcCtD
Clavulanate—Haemoglobin—Capecitabine—kidney cancer	0.00358	0.00358	CcSEcCtD
Clavulanate—Haemorrhage—Capecitabine—kidney cancer	0.00356	0.00356	CcSEcCtD
Clavulanate—Hepatitis—Capecitabine—kidney cancer	0.00356	0.00356	CcSEcCtD
Clavulanate—Hypersensitivity—Sorafenib—kidney cancer	0.00352	0.00352	CcSEcCtD
Clavulanate—Vomiting—Vinblastine—kidney cancer	0.00351	0.00351	CcSEcCtD
Clavulanate—Vomiting—Everolimus—kidney cancer	0.0035	0.0035	CcSEcCtD
Clavulanate—Rash—Everolimus—kidney cancer	0.00347	0.00347	CcSEcCtD
Clavulanate—Dermatitis—Everolimus—kidney cancer	0.00346	0.00346	CcSEcCtD
Clavulanate—Leukopenia—Paclitaxel—kidney cancer	0.00338	0.00338	CcSEcCtD
Clavulanate—Hypersensitivity—Sunitinib—kidney cancer	0.00338	0.00338	CcSEcCtD
Clavulanate—Pruritus—Sorafenib—kidney cancer	0.00338	0.00338	CcSEcCtD
Clavulanate—Vomiting—Erlotinib—kidney cancer	0.00337	0.00337	CcSEcCtD
Clavulanate—Erythema multiforme—Capecitabine—kidney cancer	0.00337	0.00337	CcSEcCtD
Clavulanate—Rash—Erlotinib—kidney cancer	0.00335	0.00335	CcSEcCtD
Clavulanate—Dermatitis—Erlotinib—kidney cancer	0.00334	0.00334	CcSEcCtD
Clavulanate—Pain—Vincristine—kidney cancer	0.00332	0.00332	CcSEcCtD
Clavulanate—Nausea—Vinblastine—kidney cancer	0.00328	0.00328	CcSEcCtD
Clavulanate—Convulsion—Paclitaxel—kidney cancer	0.00328	0.00328	CcSEcCtD
Clavulanate—Nausea—Everolimus—kidney cancer	0.00327	0.00327	CcSEcCtD
Clavulanate—Diarrhoea—Sorafenib—kidney cancer	0.00327	0.00327	CcSEcCtD
Clavulanate—Pruritus—Sunitinib—kidney cancer	0.00325	0.00325	CcSEcCtD
Clavulanate—Hypersensitivity—Dactinomycin—kidney cancer	0.0032	0.0032	CcSEcCtD
Clavulanate—Pain—Gemcitabine—kidney cancer	0.00315	0.00315	CcSEcCtD
Clavulanate—Nausea—Erlotinib—kidney cancer	0.00315	0.00315	CcSEcCtD
Clavulanate—Diarrhoea—Sunitinib—kidney cancer	0.00314	0.00314	CcSEcCtD
Clavulanate—Anaphylactic shock—Paclitaxel—kidney cancer	0.00309	0.00309	CcSEcCtD
Clavulanate—Vomiting—Sorafenib—kidney cancer	0.00304	0.00304	CcSEcCtD
Clavulanate—Hypokalaemia—Doxorubicin—kidney cancer	0.00302	0.00302	CcSEcCtD
Clavulanate—Thrombocytopenia—Paclitaxel—kidney cancer	0.00302	0.00302	CcSEcCtD
Clavulanate—Rash—Sorafenib—kidney cancer	0.00301	0.00301	CcSEcCtD
Clavulanate—Dermatitis—Sorafenib—kidney cancer	0.00301	0.00301	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00299	0.00299	CcSEcCtD
Clavulanate—Diarrhoea—Dactinomycin—kidney cancer	0.00298	0.00298	CcSEcCtD
Clavulanate—Vomiting—Sunitinib—kidney cancer	0.00292	0.00292	CcSEcCtD
Clavulanate—Rash—Sunitinib—kidney cancer	0.0029	0.0029	CcSEcCtD
Clavulanate—Dermatitis—Sunitinib—kidney cancer	0.00289	0.00289	CcSEcCtD
Clavulanate—Hypersensitivity—Vincristine—kidney cancer	0.00286	0.00286	CcSEcCtD
Clavulanate—Eosinophilia—Doxorubicin—kidney cancer	0.00284	0.00284	CcSEcCtD
Clavulanate—Nausea—Sorafenib—kidney cancer	0.00284	0.00284	CcSEcCtD
Clavulanate—Leukopenia—Capecitabine—kidney cancer	0.00278	0.00278	CcSEcCtD
Clavulanate—Vomiting—Dactinomycin—kidney cancer	0.00277	0.00277	CcSEcCtD
Clavulanate—Rash—Dactinomycin—kidney cancer	0.00274	0.00274	CcSEcCtD
Clavulanate—Nausea—Sunitinib—kidney cancer	0.00273	0.00273	CcSEcCtD
Clavulanate—Diarrhoea—Vincristine—kidney cancer	0.00266	0.00266	CcSEcCtD
Clavulanate—Pain—Paclitaxel—kidney cancer	0.00264	0.00264	CcSEcCtD
Clavulanate—Pruritus—Gemcitabine—kidney cancer	0.00261	0.00261	CcSEcCtD
Clavulanate—Nausea—Dactinomycin—kidney cancer	0.00258	0.00258	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00254	0.00254	CcSEcCtD
Clavulanate—Diarrhoea—Gemcitabine—kidney cancer	0.00252	0.00252	CcSEcCtD
Clavulanate—Thrombocytopenia—Capecitabine—kidney cancer	0.00248	0.00248	CcSEcCtD
Clavulanate—Vomiting—Vincristine—kidney cancer	0.00247	0.00247	CcSEcCtD
Clavulanate—Urticaria—Paclitaxel—kidney cancer	0.00245	0.00245	CcSEcCtD
Clavulanate—Rash—Vincristine—kidney cancer	0.00245	0.00245	CcSEcCtD
Clavulanate—Dermatitis—Vincristine—kidney cancer	0.00245	0.00245	CcSEcCtD
Clavulanate—Vomiting—Gemcitabine—kidney cancer	0.00234	0.00234	CcSEcCtD
Clavulanate—Rash—Gemcitabine—kidney cancer	0.00232	0.00232	CcSEcCtD
Clavulanate—Dermatitis—Gemcitabine—kidney cancer	0.00232	0.00232	CcSEcCtD
Clavulanate—Haemoglobin—Doxorubicin—kidney cancer	0.00231	0.00231	CcSEcCtD
Clavulanate—Nausea—Vincristine—kidney cancer	0.00231	0.00231	CcSEcCtD
Clavulanate—Hepatitis—Doxorubicin—kidney cancer	0.0023	0.0023	CcSEcCtD
Clavulanate—Haemorrhage—Doxorubicin—kidney cancer	0.0023	0.0023	CcSEcCtD
Clavulanate—Hypersensitivity—Paclitaxel—kidney cancer	0.00227	0.00227	CcSEcCtD
Clavulanate—Nausea—Gemcitabine—kidney cancer	0.00219	0.00219	CcSEcCtD
Clavulanate—Pruritus—Paclitaxel—kidney cancer	0.00218	0.00218	CcSEcCtD
Clavulanate—Erythema multiforme—Doxorubicin—kidney cancer	0.00217	0.00217	CcSEcCtD
Clavulanate—Pain—Capecitabine—kidney cancer	0.00217	0.00217	CcSEcCtD
Clavulanate—Diarrhoea—Paclitaxel—kidney cancer	0.00211	0.00211	CcSEcCtD
Clavulanate—Urticaria—Capecitabine—kidney cancer	0.00201	0.00201	CcSEcCtD
Clavulanate—Vomiting—Paclitaxel—kidney cancer	0.00196	0.00196	CcSEcCtD
Clavulanate—Rash—Paclitaxel—kidney cancer	0.00195	0.00195	CcSEcCtD
Clavulanate—Dermatitis—Paclitaxel—kidney cancer	0.00194	0.00194	CcSEcCtD
Clavulanate—Hypersensitivity—Capecitabine—kidney cancer	0.00187	0.00187	CcSEcCtD
Clavulanate—Nausea—Paclitaxel—kidney cancer	0.00183	0.00183	CcSEcCtD
Clavulanate—Pruritus—Capecitabine—kidney cancer	0.00179	0.00179	CcSEcCtD
Clavulanate—Leukopenia—Doxorubicin—kidney cancer	0.00179	0.00179	CcSEcCtD
Clavulanate—Convulsion—Doxorubicin—kidney cancer	0.00173	0.00173	CcSEcCtD
Clavulanate—Diarrhoea—Capecitabine—kidney cancer	0.00173	0.00173	CcSEcCtD
Clavulanate—Anaphylactic shock—Doxorubicin—kidney cancer	0.00163	0.00163	CcSEcCtD
Clavulanate—Vomiting—Capecitabine—kidney cancer	0.00161	0.00161	CcSEcCtD
Clavulanate—Thrombocytopenia—Doxorubicin—kidney cancer	0.0016	0.0016	CcSEcCtD
Clavulanate—Rash—Capecitabine—kidney cancer	0.0016	0.0016	CcSEcCtD
Clavulanate—Dermatitis—Capecitabine—kidney cancer	0.0016	0.0016	CcSEcCtD
Clavulanate—Nausea—Capecitabine—kidney cancer	0.0015	0.0015	CcSEcCtD
Clavulanate—Pain—Doxorubicin—kidney cancer	0.0014	0.0014	CcSEcCtD
Clavulanate—Urticaria—Doxorubicin—kidney cancer	0.0013	0.0013	CcSEcCtD
Clavulanate—Hypersensitivity—Doxorubicin—kidney cancer	0.0012	0.0012	CcSEcCtD
Clavulanate—Pruritus—Doxorubicin—kidney cancer	0.00116	0.00116	CcSEcCtD
Clavulanate—Diarrhoea—Doxorubicin—kidney cancer	0.00112	0.00112	CcSEcCtD
Clavulanate—Vomiting—Doxorubicin—kidney cancer	0.00104	0.00104	CcSEcCtD
Clavulanate—Rash—Doxorubicin—kidney cancer	0.00103	0.00103	CcSEcCtD
Clavulanate—Dermatitis—Doxorubicin—kidney cancer	0.00103	0.00103	CcSEcCtD
Clavulanate—Nausea—Doxorubicin—kidney cancer	0.00097	0.00097	CcSEcCtD
